Appendix II
Meeting Agenda
Program Presentations
Moderator: Sarah Evans, Open Society Foundations
- Werner Schneider (Germany)
- Liz Evans (Canada)
- Marianne Jauncey (Australia)
- Alexander Kral (USA)
Facilitated Questions
Facilitator: Allan Clear, Harm Reduction Coalition
- How did you decide on the type of model to use?
- Did you start with one model and move on to other models as time went on?
- Did you find one model easier to implement than others?
- What is the degree of integration of your program with other services?
- Can you comment on the benefits of stand-alone vs integrated models?
- How medicalized is your model? What clinicians are involved and what types of support do they receive?
- What type of staffing mix do you recommend?
- What is the cost of the model you chose, and what is its level of utilization?
- What is the oversight mechanism for your program?
- How have liability issues been addressed?
Policy and Research Presentations
Moderator: Sharon Stancliff, Harm Reduction Coalition
- Larry Campbell (Canada)
- Peter Frerichs (Germany)
- Tony Trimingham (Australia)
- Thomas Kerr (Canada)
Facilitated Questions
Facilitator: Daniel Raymond, Harm Reduction Coalition
Legal & Regulatory Context:
- What were the legal/regulatory barriers and how did you overcome them?
- What was the initial legal status of your model, and what is it now?
Stakeholder Support:
- How did you obtain cooperation from government?
- How did you gain public support / influence public opinion?
- How did you obtain cooperation from law enforcement — or ability to co-exist?
- What types of opposition did you encounter and how did you address it?
- How have you evaluated the impact of the program?
- What evaluation components have been most helpful in developing policy?
Lessons Learned:
- Can you talk about the pros/cons of a pilot program?
- Are there things you would do differently now than you did initially? If yes, what would that be and why?